InDex To Fly Solo With Ulcerative Colitis Drug In US
Cobitolimod Touted As Blockbuster
Approval is unlikely before 2027 but Sweden’s InDex has done the maths and decided that it can launch cobitolimod across the Atlantic on its own with a staff of around 100.
